dsk1 Antibody

Shipped with Ice Packs
In Stock

Description

Antibody Structure and Specificity

The DSK1 antibody is designed to target the Dsk1 protein kinase, a 61-kDa phosphoprotein in fission yeast (Schizosaccharomyces pombe). It exhibits high specificity for Dsk1’s phosphorylated and unphosphorylated forms, with immunoblotting and immunofluorescence assays confirming its localization to the cytoplasm during G2 phase and nuclei during mitosis .

Antibody CharacteristicsDetails
TargetDsk1 kinase
SpeciesS. pombe
ApplicationsIF, IP, WB

Immunofluorescence (IF)

The antibody visualizes Dsk1’s dynamic localization:

  • G2 phase: Cytoplasmic staining.

  • Mitosis: Intense nuclear signal .

Immunoprecipitation (IP)

Used to study Dsk1’s interactions with RS-repeat proteins (e.g., Srp1, Srp2) and its kinase activity .

Western Blot (WB)

Detects phosphorylation-dependent mobility shifts (e.g., hyperphosphorylated forms during mitotic arrest) .

Role in Mitotic Control

DSK1 regulates G2/M progression by altering phosphorylation states and kinase activity. Overexpression delays mitosis, while its absence disrupts spindle elongation in diatoms .

Phosphorylation of SR Proteins

DSK1 phosphorylates SR proteins (e.g., SF2/ASF) in vitro, with phosphorylation sites in the RS domain . This activity is conserved in human SRPK1, a functional homologue .

Spindle Elongation

In diatoms, DSK1 localizes to the spindle midzone and is essential for mitotic spindle elongation .

Table 1: DSK1 Antibody Applications

ApplicationTarget SpeciesKey Findings
ImmunofluorescenceS. pombeNuclear localization during mitosis
ImmunoprecipitationS. pombeBinds Srp1/Srp2 proteins
Western BlotS. pombeDetects phosphorylation-dependent shifts

Functional Homologues

Human SRPK1 complements dsk1 mutant phenotypes, indicating conserved SR protein phosphorylation pathways .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
dsk1 antibody; SPBC530.14cProtein kinase dsk1 antibody; EC 2.7.11.1 antibody; Dis1-suppressing protein kinase antibody
Target Names
dsk1
Uniprot No.

Target Background

Function
Dsk1 antibody may play a critical role in mitotic control by influencing cellular localization, phosphorylation levels, and kinase activity. Abundant expression of Dsk1 accelerates the exit from M-phase and delays the entry into mitosis during G2. Dsk1 phosphorylates prp2 in vitro, suggesting a potential role in coordinating pre-mRNA splicing with the progression of the cell division cycle.
Gene References Into Functions
  1. Research indicates that SR protein kinase Dsk1 is essential for efficient splicing of introns with suboptimal splice sites. PMID: 26167880
  2. Dsk1 primarily resides in the nucleus during G(2) phase and mitosis. Its localization fluctuates in a cell cycle-dependent manner. PMID: 22683458
Database Links
Protein Families
Protein kinase superfamily, Ser/Thr protein kinase family
Subcellular Location
Cytoplasm. Nucleus. Note=Enriched in the nucleus in mitotically arrested mutant and wild-type mitotic cells but cytoplasmic enriched in cells at other cell-cycle stages.

Q&A

What is DSK1 and what are its known biological functions?

DSK1 has distinct roles depending on the organism. In fission yeast, Dsk1 functions as a mitotic regulator implicated in chromosome segregation at the metaphase/anaphase transition while also serving as an SR protein-specific kinase . Genetic analyses have demonstrated its involvement in regulating chromosome segregation, while biochemical studies reveal its capacity to phosphorylate SR proteins, a family of pre-mRNA splicing factors containing arginine-serine repeats .

In diatoms such as Cylindrotheca, DSK1 is characterized as a kinesin-related protein that is significantly enriched in mitotic spindle preparations, suggesting a role in cell division machinery . This dual functionality across different organisms makes DSK1 an interesting target for comparative cellular biology studies.

How can researchers confirm the specificity of their DSK1 antibodies?

Confirming antibody specificity is crucial for reliable experimental outcomes. When working with DSK1 antibodies, researchers should:

  • Perform immunoblotting against purified recombinant DSK1 protein alongside cell/tissue lysates

  • Include appropriate negative controls (DSK1-knockout or DSK1-depleted samples)

  • Validate using orthogonal techniques such as mass spectrometry of immunoprecipitated materials

  • Test cross-reactivity against related kinases or kinesin family proteins

Specificity validation is exemplified in the literature where antibodies raised against non-conserved regions of DSK1 demonstrated enrichment in mitotic spindle preparations, confirming both specificity and localization .

What experimental applications are most suitable for DSK1 antibodies?

DSK1 antibodies have demonstrated utility in several experimental applications:

  • Immunolocalization studies: Tracking DSK1 distribution during cell cycle progression, particularly during mitosis

  • Immunoprecipitation experiments: Isolating DSK1 and its binding partners to identify novel interactions

  • Phosphorylation studies: Monitoring DSK1 kinase activity toward SR proteins

  • Western blotting: Quantifying DSK1 expression levels across different cellular conditions

  • Chromatin immunoprecipitation: Investigating potential DNA-protein interactions if DSK1 associates with chromatin regions

Selection of the appropriate application depends on specific research objectives and available antibody characteristics (monoclonal vs. polyclonal, epitope location, etc.).

How can DSK1 antibodies be used to study the relationship between pre-mRNA splicing and cell cycle regulation?

The dual functionality of Dsk1 in both cell cycle regulation and pre-mRNA splicing makes it an excellent target for investigating the coordination between these processes. Researchers can employ DSK1 antibodies to:

  • Immunoprecipitate Dsk1-containing complexes at different cell cycle stages to identify temporal changes in its interaction partners

  • Track phosphorylation states of SR proteins using phospho-specific antibodies alongside Dsk1 localization

  • Perform chromatin immunoprecipitation followed by RNA sequencing to identify specific pre-mRNA targets affected by Dsk1 activity

  • Combine with cell synchronization techniques to correlate Dsk1 kinase activity with specific cell cycle transitions

Research has shown that Dsk1 efficiently phosphorylates the fission yeast U2AF65 homolog, Prp2/Mis11 protein, suggesting this splicing factor may be an in vivo target . By using antibodies to track this relationship, researchers can elucidate how pre-mRNA processing is coordinated with cell division.

What methodological approaches can optimize immunoprecipitation with DSK1 antibodies?

Successful immunoprecipitation of DSK1 requires careful optimization:

ParameterRecommended ApproachRationale
Lysis bufferLow-to-moderate salt (150-300mM NaCl) with 0.1-1% non-ionic detergentPreserves protein-protein interactions while solubilizing membrane components
Antibody immobilizationCovalent coupling to protein A/G beadsPrevents antibody co-elution with the target protein
Pre-clearing stepPre-incubate lysate with beads without antibodyReduces non-specific binding
Washing stringencyGradual increase in salt concentrationRemoves weak non-specific interactions while preserving specific ones
Elution methodNative: competitor peptide
Denaturing: SDS buffer
Choose based on downstream applications

For kinase activity studies, researchers should consider including phosphatase inhibitors in all buffers to preserve the phosphorylation state of DSK1 and its substrates. When studying SR protein interactions, the immunoprecipitation protocol should be adapted to account for the highly charged nature of these proteins by adjusting salt concentrations accordingly .

How do phosphorylation states affect DSK1 antibody recognition and experimental outcomes?

The phosphorylation state of DSK1 can significantly impact antibody recognition, particularly if the epitope contains potential phosphorylation sites. Research considerations include:

  • Epitope-specific effects: Antibodies targeting regions containing phosphorylation sites may show differential binding depending on phosphorylation status

  • Functional state detection: Phospho-specific antibodies can distinguish between active and inactive DSK1 forms

  • Experimental controls: Include both phosphatase-treated and untreated samples when characterizing new antibodies

  • Context-dependent recognition: The cellular environment (cell cycle stage, stress conditions) may alter DSK1 phosphorylation and subsequent antibody recognition

When working with phosphorylation-sensitive antibodies, remember that monoclonal antibodies (mAbs) like mAb104, which recognizes a phosphoepitope shared by SR proteins, can be valuable tools to detect specific phosphorylation events . This approach can be adapted to study DSK1 phosphorylation status across different experimental conditions.

What are common pitfalls when using DSK1 antibodies and how can they be addressed?

Researchers frequently encounter several challenges when working with DSK1 antibodies:

  • Non-specific binding:

    • Problem: High background signal in immunoblots or immunofluorescence

    • Solution: Increase blocking stringency (5% BSA or milk), optimize antibody dilution, and include appropriate controls

  • Epitope masking:

    • Problem: Reduced signal due to protein-protein interactions obscuring the epitope

    • Solution: Test various fixation protocols or denaturing conditions

  • Cross-reactivity with related proteins:

    • Problem: False positive signals from related kinases or kinesin family members

    • Solution: Validate with knockout/knockdown samples and peptide competition assays

  • Batch-to-batch variability:

    • Problem: Inconsistent results between antibody lots

    • Solution: Standardize validation protocols and maintain reference samples for comparison

When troubleshooting, it's instructive to note techniques from the literature, such as the approach used for anti-DKK1-A2 antibody validation, which employed multiple complementary methods including ELISA, confocal imaging, and flow cytometry to confirm specificity .

How can researchers effectively use DSK1 antibodies to study its kinase activity toward SR proteins?

To effectively study DSK1's kinase activity toward SR proteins, researchers should consider:

  • In vitro kinase assays:

    • Purify recombinant DSK1 and SR protein substrates

    • Perform kinase reactions with radioactive or non-radioactive ATP

    • Use phospho-specific antibodies to detect phosphorylation events

  • Substrate validation:

    • Employ purified components to demonstrate direct phosphorylation

    • Use phospho-deficient mutants as negative controls

    • Compare phosphorylation efficiency with known SR protein kinases like SRPK1

  • Phosphorylation site mapping:

    • Use mass spectrometry to identify specific residues phosphorylated by DSK1

    • Generate phospho-specific antibodies for these sites

    • Create phospho-mimetic and phospho-deficient mutants for functional studies

As demonstrated in the literature, Dsk1 phosphorylates human and yeast SR proteins with high specificity, and the phosphorylation sites appear to reside in the RS domain as evidenced by strong recognition by mAb104, which binds the in vivo phosphoepitope shared by SR proteins .

What approaches can be used to study the spatial and temporal dynamics of DSK1 using antibodies?

Understanding DSK1's spatial and temporal dynamics requires sophisticated methodological approaches:

  • Live-cell imaging:

    • Generate cell lines expressing fluorescently-tagged DSK1

    • Validate localization patterns with fixed-cell immunofluorescence using DSK1 antibodies

    • Track DSK1 movement during cell cycle progression

  • Cell synchronization strategies:

    • Synchronize cells at specific cell cycle stages

    • Use DSK1 antibodies to track expression and localization changes

    • Correlate with known cell cycle markers

  • Super-resolution microscopy:

    • Employ techniques like STORM or PALM with DSK1 antibodies

    • Resolve sub-cellular localization with nanometer precision

    • Co-localize with interaction partners

  • Proximity labeling:

    • Use DSK1 antibodies to validate BioID or APEX2 proximity labeling results

    • Identify proteins in close proximity to DSK1 at different cell cycle stages

This multi-faceted approach is supported by findings showing DSK1 enrichment in mitotic spindle preparations, suggesting important temporal regulation during mitosis .

How might DSK1 antibodies contribute to understanding evolutionary conservation of kinase function?

DSK1 antibodies can serve as valuable tools for comparative studies across species:

  • Cross-species reactivity testing:

    • Evaluate antibody recognition of DSK1 homologs across evolutionary distant organisms

    • Map conserved epitopes through sequence alignment and structural analysis

    • Develop pan-specific antibodies targeting highly conserved regions

  • Functional conservation assessment:

    • Compare phosphorylation patterns of SR proteins by DSK1 homologs

    • Evaluate cell cycle roles in different model systems

    • Characterize species-specific interaction partners

  • Structural biology applications:

    • Use antibodies as crystallization chaperones for structural studies

    • Compare binding epitopes across species through hydrogen-deuterium exchange mass spectrometry

This approach is particularly relevant given the different reported roles of DSK1 across species, from SR protein kinase activity in fission yeast to kinesin-related functions in diatoms .

What techniques can optimize the generation of phospho-specific DSK1 antibodies for research?

Generation of phospho-specific DSK1 antibodies requires specialized approaches:

  • Phosphopeptide design considerations:

    • Select peptides containing known or predicted phosphorylation sites

    • Include 5-7 amino acids flanking the phosphorylation site

    • Consider multiple phosphorylation states (mono-, di-, or tri-phosphorylated)

  • Immunization and screening strategies:

    • Immunize with phosphopeptide conjugated to carrier protein

    • Screen antibody clones against both phosphorylated and non-phosphorylated peptides

    • Validate specificity using phosphatase-treated controls

  • Purification approaches:

    • Perform tandem affinity purification using both phospho and non-phospho peptides

    • Employ negative selection to remove antibodies recognizing non-phosphorylated epitopes

    • Validate with phospho-null mutants (S/T to A) and phospho-mimetic mutants (S/T to D/E)

These technical considerations are similar to those employed for developing specific monoclonal antibodies against other phospho-epitopes, as exemplified by techniques used for developing therapeutic antibodies against complex targets .

How can DSK1 antibodies be integrated with emerging single-cell technologies?

Integrating DSK1 antibodies with single-cell technologies offers exciting research opportunities:

  • Single-cell proteomics:

    • Use DSK1 antibodies in mass cytometry (CyTOF) panels

    • Correlate DSK1 expression/modification with other cellular parameters

    • Identify rare cell populations with unique DSK1 activity profiles

  • Spatial transcriptomics correlation:

    • Combine DSK1 immunostaining with spatial transcriptomics

    • Correlate DSK1 localization with gene expression patterns

    • Map cellular neighborhoods defined by DSK1 activity

  • Multimodal single-cell analysis:

    • Integrate antibody-based detection with transcriptomics (CITE-seq approaches)

    • Link DSK1 protein levels with transcript expression

    • Profile individual cells across multiple molecular dimensions

These emerging approaches can reveal cell-to-cell heterogeneity in DSK1 expression, localization, and activity that would be masked in population-based studies, providing deeper insights into its functional roles across different cellular contexts.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.